This program uses compounded semaglutide or tirzepatide, which are non-branded medications that are not FDA-approved
Abbasinejad uses her extensive knowledge to provide personalized treatment plans that not only address weight loss but also promote overall health and wellness, ensuring lasting results

Choosing Between Semaglutide and Tirzepatide Based on Eligibility You May Be Better Suited for Semaglutide If You prefer steady progress You have mild metabolic slowdown You experience digestive sensitivity You fall at the lower end of the eligibility BMI range You May Be Better Suited for Tirzepatide If You struggle with strong appetite dysregulation You have significant insulin resistance You previously plateaued on Semaglutide You have a higher BMI or desire more rapid improvement Realistic Expectations for Eligible Patients Once on a therapeutic dose most patients experience Early appetite changes Steady weekly weight loss Improved blood sugar stability Higher energy and better mood Fifteen to thirty percent reduction in baseline weight over time GLP-1s support long term metabolic resetting when monitored properly
A Fellow of the Royal Society, London, Druckers discoveries have been recognized by numerous scientific and medical societies
GLP-1 biology isnt about duration, its about precision
The differential effect of GLP-1R agonists on capsaicin and ATP responses in neurons suggest they may not affect pain mechanisms mediated by the capsaicin receptor TRPV1, but may enhance the effects of purinergic agonists